We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SEC Clears Accounting Hurdle for Stockpile Vaccines
SEC Clears Accounting Hurdle for Stockpile Vaccines
December 9, 2005
Drug manufacturers that provide vaccines for government stockpiles can recognize revenue from the sales immediately instead of having to wait to book the sales until the drugs are distributed, according to the SEC.